Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FDM40
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $445,044
Award facts
- Contract value 100% obligated
- $445,043.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $445,043.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 29, 2025, for the supply of Entyvio 300 mg vials. The contract, with an ultimate completion date of October 21, 2025, will be fulfilled from the contractor's facility in Park Ridge, Illinois. This delivery order was issued without a set-aside designation, enabling DMS Pharmaceutical Group to compete openly in the federal procurement marketplace despite its status as a woman-owned small business.
DMS Pharmaceutical Group Inc. is a well-established pharmaceutical wholesaler that has served as a critical supplier to federal healthcare systems since its SAM.gov registration in 2001. This award is issued under the company's existing single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense medical facilities. The delivery order for Entyvio, a specialized biologic medication, exemplifies the company's portfolio of branded and generic pharmaceutical distributions to military and federal healthcare installations nationwide.
Quick answers
Who was awarded contract SPE2DB25FDM40?
SPE2DB25FDM40 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FDM40 worth?
The government has obligated $445,044 on SPE2DB25FDM40.
Is contract SPE2DB25FDM40 an order under another contract?
Yes. SPE2DB25FDM40 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM40 competed?
The extent of competition for SPE2DB25FDM40 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award